Intracellular, time-resolved speciation and quantification of arsenic compounds in human urothelial and hepatoma cells

Journal of Analytical Atomic Spectrometry

Volumn 26, Issue 12, 2011, Pages 2396-2403

  Hippler, Joerg ^a   Zdrenka, Ricarda ^b   Reichel, Robin A D ^a   Weber, Daniel G ^c   Rozynek, Peter ^c   Johnen, Georg ^c   Dopp, Elke ^b   Hirner, Alfred V ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC SPECIES; ARSENIC TRIOXIDE; BIOTRANSFORMATION PRODUCT; BLADDER CANCERS; CANCER THERAPY; CELLULAR STRUCTURE; CHRONIC EXPOSURE; DIMETHYLARSENIC ACID; DIMETHYLARSINOUS ACID; HEPATOCYTES; HEPATOMA CELLS; HEPG2 CELLS; LOW DOSE; LYSATES; MAMMALIAN CELLS; METABOLIC PATHWAYS; MONOMETHYLARSONIC ACIDS; MONOMETHYLARSONOUS ACIDS; OXIDATION PRODUCTS; TIME-RESOLVED; UROTHELIAL CELLS;

ALKYLATION; ARSENIC; CELLS; DISEASES; MAMMALS; METABOLISM;

ARSENIC COMPOUNDS;

EID: 81255129465     PISSN: 02679477     EISSN: 13645544     Source Type: Journal    
DOI: 10.1039/c1ja10150a     Document Type: Article

References (41)

1. WHO (World health organization), Arsenic Compounds, Environmental Health Criteria 224, 2nd edn, WHO, Geneva, 2001
2. WHO (World health organization, regional office for south-east asia), A Field Guide for Detection, Management and Surveillance of Arsenicosis Cases, WHO, New Delhi, 2005
3. Y. Nakajima Y. Endo Y. Inoue K. Yamanaka K. Kato H. Wanibuchi G. Endo Appl. Organomet. Chem. 2006 20 557 564
4. C. Newcombe A. Raab P. N. Williams C. Deacon P. I. Haris A. A. Meharg J. Feldmann J. Environ. Monit. 2010 12 832 837
5. K. A. Francesconi Pure Appl. Chem. 2010 82 373 381
6. B. K. Mandal K. T. Suzuki Talanta 2002 58 201 235
7. H. Naranmandura K. T. Suzuki Toxicol. Appl. Pharmacol. 2008 227 390 399
8. H. Naranmandura N. Suzuki K. Iwata S. Hirano K. T. Suzuki Chem. Res. Toxicol. 2007 20 616 624
9. IARC (International Agency for Research on Cancer) Arsenic and Arsenic Compounds, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, IARC, Lyon, 1980, vol. 23, pp. 39-141
10. A. H. Smith C. Hopenhaynrich M. N. Bates H. M. Goeden I. Hertzpicciotto H. M. Duggan R. Wood M. J. Kosnett M. T. Smith Environ. Health Perspect. 1992 97 259 267
11. G. Hanrahan T. K. Fan M. Kantor K. Clark S. Cardenas D. W. Guillaume C. S. Khachikian Rev. Sci. Instrum. 2009 80 104101/1
12. K. H. Antmann Oncologist 2001 6 1 2
13. I. Koch S. Sylvester V. W. M. Lai A. Owen K. J. Reimer W. R. Cullen Toxicol. Appl. Pharmacol. 2007 222 357 364
14. E. Dopp, A. D. Kligermann and R. A. Diaz-Bone, Organoarsenicals, Uptake, Metabolism, and Toxicity, in Metal Ions in Life Sciences, ed., A. Sigel, H. Sigel, and, R. K. O. Sigel, RSC Publishing, Cambridge, 2010, vol. 7, pp. 231-265
15. A. V. Hirner and A. W. Rettenmeier, Methylated Metal(loid) Species in Humans, in Metal Ions in Life Sciences, ed., A. Sigel, H. Sigel, and, R. K. O. Sigel, RSC Publishing, Cambridge, 2010, vol. 7, pp. 465-512
16. H. Naranmandura N. Suzuki K. T. Suzuki Chem. Res. Toxicol. 2006 19 1010 1018
17. S. Wangkarn S. A. Pergantis J. Anal. At. Spectrom. 2000 15 627 633
18. H. H. Wellhöner, Allgemeine und Systematische Pharmakologie und Toxikologie, Springer, Berlin, 6th edn, 1997, ch. 24.9, pp. 553-566
19. E. Dopp U. von Recklinghausen R. Diaz-Bone A. V. Hirner A. W. Rettenmeier Environ. Res. 2010 110 435 442
20. R. Zdrenka, J. Hippler, G. Johnen, A. V. Hirner and E. Dopp, Intracellular Arsenic Speciation and Quantification in Human Urothelial and Hepatic Cells, in Bladder Cancer, ed., A. Canda, and, A. Ataturk, Intech Open Access Publisher, accepted, ISBN: 978-953-307-610-2
21. M. Styblo D. J. Thomas Toxicol. Appl. Pharmacol. 1997 147 1 8
22. H. Yan N. Wang M. Weinfeld W. R. Cullen X. C. Le Anal. Chem. 2009 81 4144 4152
23. S. H. Lam C. L. Winata Y. Tong S. Korzh W. S. Lim V. Korzh J. Spitsbergen S. Mathavan L. D. Miller E. T. Liu Z. Gong Physiol. Genomics 2006 27 351 361
24. C. Marques P. Pereira A. Taylor J. N. Liang V. N. Reddy L. I. Szweda F. Shang Faseb. J. 2004 18 1424 1426
25. H. Barriere C. Nemes K. Du G. L. Lukacs Mol. Biol. Cell 2007 18 3952 3965
26. I. L. Arancibia-Cárcamo E. Y. Youen J. Muir M. J. Lumb G. Michels R. S. Saliba T. G. Smart Z. Yan J. T. Kittler S. J. Moss Proc. Natl. Acad. Sci. U. S. A. 2009 106 17552 17557
27. S. K. Shenoy K. Xiao V. Venkataramanan P. M. Snyder N. J. Freedmann A. M. Weissmann J. Biol. Chem. 2008 283 22166 22176
28. T. G. Bredfeldt M. J. Kopplin A. J. Gandolfi Toxicol. Appl. Pharmacol. 2004 198 412 418
29. C.-S. Chen BMC Cell Biol. 2002 3 21
30. A. Terman T. Kurz B. Gustafsson U. T. Brunk IUBMB Life 2006 58 531 539
31. Y. Yang Z. Liang B. Gao Y. Jia Z. Qin Acta Pharmacol. Sin. 2008 29 123 134
32. M. Mehrpour A. Esclatine I. Beau P. Codogno Cell Res. 2010 20 748 762
33. M. J. Clague S. Urbé Cell 2010 143 682 685
34. M. Kundu C. B. Thompson Annu. Rev. Pathol.: Mech. Dis. 2008 3 427 455
35. S. Kitareewan B. D. Roebuck E. Demidenko R. D. Sloboda E. Dmitrovski J. Natl. Cancer Inst. 2007 99 41 52
36. Z.-X. Du H.-Y. Zhang X. Meng Y. Guan H.-Q. Wang BMC Cancer 2009 9 56
37. M. E. Anderson Chem.-Biol. Interact. 1998 111-112 1 14
38. E. Dopp U. von Recklinghausen L. M. Hartmann I. Stueckradt I. Pollok S. Rabieh L. Hao A. Nussler C. Katier A. V. Hirner A. W. Rettenmeier Drug Metab. Dispos. 2008 36 971 979
39. T. Hayakawa Y. Kobayashi X. Cui S. Hirano Arch. Toxicol. 2005 79 183 191
40. X. Chris Le X. Lu M. Ma W. R. Cullen H. V. Aposhian B. Zheng Anal. Chem. 2000 72 5172 5177
41. M. Styblo L. M. Del Razo L. Vega D. R. Germolec E. L. LeCluyse G. A. Hamilton W. Reed C. Wang W. R. Cullen D. J. Thomas Arch. Toxicol. 2000 74 289 299